We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Hikma Pharmaceuticals plc (PK) | USOTC:HKMPY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.87 | -1.69% | 50.66 | 49.63 | 51.63 | 52.10 | 50.65 | 52.10 | 1,516 | 21:01:21 |
From Jun 2019 to Jun 2024
Abbott's head of innovation and development for the emerging markets is called Todd Chermak. "Drug Makers Find 'Branded Generics' Are a Source for Growth," at 1210 GMT incorrectly stated his surname as Todd Chermark in the 24th paragraph.
(END) Dow Jones Newswires
October 23, 2017 11:03 ET (15:03 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Hikma Pharmaceuticals (PK) Chart |
1 Month Hikma Pharmaceuticals (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
